The state of Georgia currently has 19 active clinical trials seeking participants for Type 2 Diabetes research studies. These trials are conducted in various cities, including Atlanta, Augusta, Decatur and Savannah.
Innovative Automated Insulin Delivery System for Type 2 Diabetes
NCT06853990
Recruiting
The goal of this clinical trial is to learn if the twiist insulin delivery system works to treat adults with insulin-treated type 2 diabetes.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
06/03/2025
Locations: Endocrine Research Solutions, Inc, Roswell, Georgia
Conditions: Type 2 Diabetes, Insulin Treated Type 2 Diabetes Mellitus
Register for Updates
CGM and DFU Healing Post-discharge
NCT06054659
Recruiting
The purpose of this study is to look at the benefits of using a Continuous Glucose Monitoring (CGM) system compared with standard-of-care testing for patients with diabetes type 2 and diabetic foot ulcers (DFU) and how this will improve wound healing. The CGM system allows medical staff and patients with diabetes to monitor and make treatment decisions to improve glucose control, without the need for performing fingersticks. Hence, the use of CGM will decrease the painful and burdensome task of... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
04/29/2025
Locations: Grady Health System, Atlanta, Georgia
Conditions: Diabetic Foot, Diabetes Type 2 With Diabetic Ulcer of Toe, Skin Breakdown
Register for Updates
A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM
NCT06897202
Recruiting
This study is designed to test how well once-weekly MET097 (an ultra-long-acting GLP-1 receptor agonist) works to treat adults with obesity or overweight and type 2 diabetes mellitus (T2DM) compared to placebo. MET097 or placebo will be administered to individuals via subcutaneous injection once weekly for 28 weeks. If an individual is randomly assigned to MET097 they will receive one of four different dose regimens.
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
04/09/2025
Locations: Research Site 097202-001002, Decatur, Georgia +1 locations
Conditions: Obesity in Diabetes, Type 2 Diabetes Mellitus (T2DM)
Register for Updates
Wild Blueberries for Gut, Brain, and Heart Health in Adults with High Blood Pressure
NCT06735599
Recruiting
The purpose of the study is to determine the effectiveness of wild blueberries on cardiovascular health, cognitive function, and gut microbiota composition in non-Hispanic Black and White adults with elevated blood pressure.
Gender:
ALL
Ages:
Between 45 years and 65 years
Trial Updated:
03/18/2025
Locations: Georgia State University, Atlanta, Georgia
Conditions: Hypertension (without Type 2 Diabetes Mellitus), High Blood Pressure, Male, Female, Adult, Cognition, Endothelial Function (reactive Hyperemia), Oxidative Stress, Diet, Overweight, Body Composition Measurement, Gut Microbiome, Arterial Stiffness, Caucasian Whites, Inflammation, Microvascular Function
Register for Updates
Mobile App Logging for Diabetes in Pregnancy
NCT06005987
Recruiting
To determine the effect of using a mobile app versus paper logs on compliance and percentage in range blood sugars in monitoring blood sugar in pregnant women with diabetes.
Gender:
FEMALE
Ages:
Between 18 years and 100 years
Trial Updated:
01/29/2025
Locations: Augusta University, Augusta, Georgia
Conditions: Gestational Diabetes Mellitus in Pregnancy, Type 2 Diabetes
Register for Updates
Automated Insulin Delivery for Inpatients with Dysglycemia
NCT06418880
Recruiting
This randomized controlled trial will test the efficacy and safety of automated insulin delivery (AID) in hospitalized patients with diabetes (type 1 or type 2) requiring insulin therapy who are admitted to general medical/surgical floors. The main objectives of this study are: * To test the efficacy and safety of AID versus multiple daily insulin injections (MDI) + CGM in the inpatient setting * To determine differences in CGM-derived metrics between AID and MDI plus CGM in the hospital and e... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
01/27/2025
Locations: Grady Health System (non-CRN), Atlanta, Georgia
Conditions: Type 1 Diabetes, Type 2 Diabetes
Register for Updates
Glycemic Excursion Minimization (GEM) to Outshine Health Disparities
NCT06236581
Recruiting
The purpose of this study is to see if the GEM intervention is acceptable and helpful to Black adults with type 2 diabetes. The GEM intervention (coaching to reduce carbohydrate intake and increase physical activity after meals, with feedback from a continuous glucose monitor, CGM) might improve blood glucose levels, reduce diabetes distress, and increase empowerment and confidence in managing diabetes.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
07/29/2024
Locations: Georgia Prevention Institute, Augusta, Georgia
Conditions: Type 2 Diabetes
Register for Updates